Skip to main content
Equibles

DEUTSCHE BANK AG\

Bank

Position in EDIT — Editas Medicine, Inc.

CIK 948046 FRANKFURT AM MAIN, 2M
Back to EDIT Full portfolio

Position in EDIT

as of Jun 30, 2026 · filed Aug 7, 2026
Position Value
$321,942
+$46,820 QoQ
Shares Held
99,365
+25.3% QoQ
Ownership
0.065%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#68
of 216 holders
Holding Since
Mar 2020
22 quarters on record
Voting authority Sole 2% Shared 0% None 98%

Common Shares in EDIT Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

DEUTSCHE BANK AG\ holds $3,199,137,357 across 296 Biotechnology names. EDIT ranks #207 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 1,579,110 $784,391,303
2 REGN
Regeneron Pharmaceuticals, Inc.
 518,409 $323,248,743
3 ALNY
Alnylam Pharmaceuticals, Inc.
 815,400 $245,459,858
4 RVMD
Revolution Medicines, Inc.
 888,019 $166,308,196
5 RPRX
Royalty Pharma plc
 2,717,951 $152,395,510
6 INCY
Incyte Corp
 1,262,988 $143,172,312
7 ARGX
Argenx SE
 137,335 $127,415,291
8 LGND
Ligand Pharmaceuticals Inc
 249,611 $78,899,539

All Filings in EDIT

Export CSV
22 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $321,942 99,365
2025-09-30 $275,122 79,286
2025-06-30 $153,051 69,569
2024-09-30 $302,050 88,578
2024-06-30 $346,756 74,252
2024-03-31 $598,868 80,710
2023-12-31 $807,229 79,687
2023-09-30 $561,303 71,962
2023-06-30 $553,969 67,311
2023-03-31 $1,466,957 202,339
2022-12-31 $2,311,752 260,626
2022-09-30 $929,553 75,944
2022-06-30 $898,937 75,988
2022-03-31 $1,541,645 81,054
2021-12-31 $2,319,034 87,346
2021-09-30 $3,769,869 91,769
2021-06-30 $2,673,916 47,209
2021-03-31 $2,563,596 61,038
2020-12-31 $3,720,314 53,064
2020-09-30 $1,089,062 38,812
2020-06-30 $1,176,957 39,789
2020-03-31 $442,307 22,305